EUVIMEDEUVIMED entdecken
Fallbericht

Therapeutic hopes for CFTR-related recurrent pancreatitis: a case-series

Sophie Gohy, Anaïs Le, Isabelle Sermet-Gaudelus, Elke De Wachter, Angélique Lhomme, François Vermeulen, Isabelle Scheers

Journal of Cystic Fibrosis · 2026

DOI: 10.1016/j.jcf.2026.02.008 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Cystic Fibrosis, 2026. Verfasst von Sophie Gohy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pneumology department, Cliniques universitaires Saint-Luc, Brussels, Belgium; Cystic fibrosis reference center, Cliniques universitaires Saint-Luc, B…. Hauptthemen laut MEDLINE: Aminophenols, Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Pancreatitis. Die Arbeit nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The presence of CFTR variants increases the risk of pancreatitis in pancreatic sufficient people with cystic fibrosis (pwCF) or with CFTR-related disorder (pwCFTR-RD). Modulators have been showed to decrease pancreatitis episodes in pwCF presenting recurrent pancreatitis. Whether CFTR modulators are efficient to prevent recurrent episodes of pancreatitis in pwCFTR-RD is not known. We collected clinical, biological, imaging and CFTR functional data in 4 patients with recurrent pancreatitis and CFTR-RD, treated with CFTR modulators and assessed the efficacy of the treatment. With a follow-up of minimum 9 months, we found that ETI and ivacaftor reduced or even resolved the number of acute pancreatitis episodes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AminophenolsCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorPancreatitisQuinolonesFemaleHumansMaleChloride Channel AgonistsRecurrenceChildAdolescentYoung Adult

Stichwörter der Autor:innen

CFTR modulatorsCystic fibrosis and CFTR related diseaseETIIvacaftorPancreatitis

Substanzen

AminophenolsCFTR protein, humanChloride Channel AgonistsCystic Fibrosis Transmembrane Conductance RegulatorivacaftorQuinolones

Autor:innen und Institutionen

  • Pneumology department, Cliniques universitaires Saint-Luc, Brussels, Belgium; Cystic fibrosis reference center, Cliniques universitaires Saint-Luc, Brussels, Belgium; European Reference Network-Respiratory Diseases (ERN…
  • INSERM U1151, Université Paris Cité, Centre de Références Maladies Rares Mucoviscidose et Maladies Apparentées, Hôpital Necker Enfants Malades, Paris, France.
  • Department of Pediatrics, Cystic fibrosis reference center, UZ Brussel, Brussels, Belgium.
  • Department of Pediatrics, Cystic fibrosis reference center, CHR/CHU Liège, Liège, Belgium.
  • Cystic fibrosis reference center, Woman and Child Unit, Department of Development and Regeneration, KU Leuven, Leuven, Belgium; Department of Pediatrics, Pediatric Pulmonology, UZ Leuven, Leuven, Belgium.
  • Cystic fibrosis reference center, Cliniques universitaires Saint-Luc, Brussels, Belgium; Department of Pediatric Gastroenterology and Hepatology, Cliniques universitaires Saint-Luc, Université catholique de Louvain (UCL…

Zitieren

APA

Gohy, S., Le, A., Sermet-Gaudelus, I., De Wachter, E., Lhomme, A., Vermeulen, F., & Scheers, I. (2026). Therapeutic hopes for CFTR-related recurrent pancreatitis: a case-series. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2026.02.008

Vancouver

Gohy S, Le A, Sermet-Gaudelus I, De Wachter E, Lhomme A, Vermeulen F, et al. Therapeutic hopes for CFTR-related recurrent pancreatitis: a case-series. Journal of Cystic Fibrosis. 2026. doi:10.1016/j.jcf.2026.02.008

BibTeX
@article{Gohy2026,
  author = {Gohy, Sophie and Le, Anaïs and Sermet-Gaudelus, Isabelle and De Wachter, Elke and Lhomme, Angélique and Vermeulen, François and Scheers, Isabelle},
  title = {Therapeutic hopes for CFTR-related recurrent pancreatitis: a case-series},
  journal = {Journal of Cystic Fibrosis},
  year = {2026},
  doi = {10.1016/j.jcf.2026.02.008}
}
Kostenlos starten →